4.5 Article

A mutation in CLOCK leads to altered dopamine receptor function

期刊

JOURNAL OF NEUROCHEMISTRY
卷 123, 期 1, 页码 124-134

出版社

WILEY
DOI: 10.1111/j.1471-4159.2012.07857.x

关键词

circadian; dopamine; locomotion; pharmacology; protein; receptors

资金

  1. National Institutes of Health [MH79710, MH083711, DA016672, DA033485, MH082876, MH090683, DA023988]
  2. Pfizer
  3. GlaxoSmithKline

向作者/读者索取更多资源

Mice with a mutation in the Clock gene (Clock?19) have a number of behavioral phenotypes that suggest alterations in dopaminergic transmission. These include hyperactivity, increased exploratory behavior, and increased reward value for drugs of abuse. However, the complex changes in dopaminergic transmission that underlie the behavioral abnormalities in these mice remain unclear. Here we find that a loss of CLOCK function increases dopamine release and turnover in striatum as indicated by increased levels of metabolites HVA and DOPAC, and enhances sensitivity to dopamine receptor antagonists. Interestingly, this enlarged dopaminergic tone results in downstream changes in dopamine receptor (DR) levels with a surprising augmentation of both D1- and D2-type DR protein, but a significant shift in the ratio of D1 : D2 receptors in favor of D2 receptor signaling. These effects have functional consequences for both behavior and intracellular signaling, with alterations in locomotor responses to both D1-type and D2-type specific agonists and a blunted response to cAMP activation in the Clock?19 mutants. Taken together, these studies further elucidate the abnormalities in dopaminergic transmission that underlie mood, activity, and addictive behaviors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据